Floatz logo

315 assets in Malignant Pancreatic Neoplasm

Therapeutic assets addressing Malignant Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer
Malignant Pancreatic Neoplasm
Chinese PLA General HospitalP4BBB (76)
Metformin
Malignant Pancreatic Neoplasm
State University of New York - Downstate Medical CenterP2BBB (75)
Fluorouracilum
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP4BBB (74)
Irinotecan
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP3BB (71)
Oxaliplatin
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP4BB (71)
Cis-Diamminedichloroplatinum Ii
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP2/3BB (70)
Olaparib
Malignant Pancreatic Neoplasm
MOMA TherapeuticsP2BB (70)
Tunlametinib
Malignant Pancreatic Neoplasm
Chinese PLA General HospitalP4BB (70)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
Malignant Pancreatic Neoplasm
Baki TopalP2BB (68)
S-1
Malignant Pancreatic Neoplasm
Ruijin HospitalP4BB (68)
Selumetinib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P2BB (67)
Bortezomib
Malignant Pancreatic Neoplasm
Zhejiang UniversityP2BB (66)
Capecitabine
Malignant Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and HospitalP4BB (66)
Cetuximab
Malignant Pancreatic Neoplasm
Chinese PLA General HospitalP4BB (66)
Dasatinib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2BB (66)
Docetaxel
Malignant Pancreatic Neoplasm
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P3BB (66)
Durvalumab
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP2BB (66)
Pembrolizumab
Malignant Pancreatic Neoplasm
Essen BiotechP2BB (66)
Serplulimab
Malignant Pancreatic Neoplasm
Zhejiang Cancer HospitalP3BB (66)
Creon
Malignant Pancreatic Neoplasm
Hospital Clinico Universitario de SantiagoP4BB (65)
Huaier Granule
Malignant Pancreatic Neoplasm
Xi'an Jiaotong UniversityP4BB (65)
Nivolumab
Malignant Pancreatic Neoplasm
Mayo ClinicP2BB (65)
Palbociclib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P2BB (65)
Vismodegib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2BB (65)
Anti-Cea Car-T Cells
Malignant Pancreatic Neoplasm
Sorrento Therapeutics, Inc.P2/3BB (64)
Panitumumab
Malignant Pancreatic Neoplasm
SWOG Cancer Research NetworkP3BB (64)
Surufatinib
Malignant Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
Carboplatin
Malignant Pancreatic Neoplasm
AkesoP2B (63)
Trastuzumab Emtansine
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2B (63)
Veliparib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P2B (63)
Cobimetinib
Malignant Pancreatic Neoplasm
N.N. Petrov National Medical Research Center of OncologyP2B (62)
Dynamos
Malignant Pancreatic Neoplasm
State University of New York - Downstate Medical CenterP2B (62)
Irinotecan Sucrosofate
Malignant Pancreatic Neoplasm
SWOG Cancer Research NetworkP3B (62)
Levofolinic Acid
Malignant Pancreatic Neoplasm
Zhejiang UniversityP2B (62)
Sorafenib
Malignant Pancreatic Neoplasm
HonorHealth Research InstituteP2B (62)
Toripalimab
Malignant Pancreatic Neoplasm
Ruijin HospitalP2B (62)
Adebrelimab
Malignant Pancreatic Neoplasm
West China HospitalP2B (60)
Adriamycin
Malignant Pancreatic Neoplasm
Moscow Clinical Scientific CenterP2B (60)
Atezolizumab
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2B (60)
Avutometinib
Malignant Pancreatic Neoplasm
Washington University School of MedicineP2B (60)
Enoxaparin
Malignant Pancreatic Neoplasm
Helsinki University Central HospitalP4B (60)
Entinostat
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)P2B (60)
Hydroxychloroquine
Malignant Pancreatic Neoplasm
N.N. Petrov National Medical Research Center of OncologyP2B (60)
Ipilimumab
Malignant Pancreatic Neoplasm
Centre Georges Francois LeclercP2B (60)
Ivospemin
Malignant Pancreatic Neoplasm
Panbela Therapeutics, Inc.P2/3B (60)
Lenvatinib
Malignant Pancreatic Neoplasm
Du JuanP2B (60)
Niraparib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2B (60)
Regorafenib
Malignant Pancreatic Neoplasm
Junjie HangP2B (60)
Retifanlimab
Malignant Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2B (60)
Sargramostim
Malignant Pancreatic Neoplasm
Barbara Ann Karmanos Cancer InstituteP1/2B (60)
Showing 1 to 50 of 315 assets
PreviousPage 1 of 7Next